You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 0.0% | n/a |
| ROCE | 910.4% |
| Latest | Forecast | |
|---|---|---|
| P/E | -3.7 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.0 | 0.0 |
| Price / Book value | -12.2 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 0.0% | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | -12.5% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (€m) |
Pre-tax (€m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | n/a | -13.25 | €-0.36 | -8.6 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | n/a | -16.93 | €-0.37 | -7.9 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | n/a | -21.18 | €-0.42 | -7.6 | 0.0 | n/a | n/a | 0.0% |
| 2022-12-31 | 0.00 | -28.73 | €-0.52 | -6.5 | 0.0 | n/a | n/a | 0.0% |
| 2023-12-31 | 0.00 | -30.94 | €-0.48 | -7.3 | 0.0 | n/a | n/a | 0.0% |
| Faron Pharmaceuticals files new patent for Clever-1 Sharecast News | 11 Nov |
|---|---|
| Faron Pharmaceuticals candidate gets FDA fast track designation Sharecast News | 27 Aug |
| Faron gets positive FDA feedback on bexmarilimab study plans Sharecast News | 11 Jul |
| Shareholders’ Nomination Board | 05-Nov-24 07:01 |
|---|---|
| Faron’s Capital Markets Day 2024 | 22-Oct-24 07:01 |
| Grant of options | 30-Aug-24 07:01 |
| Faron 2024 Half-Year Financial Results | 27-Aug-24 07:01 |
| FDA Grants Fast Track Designation for Bexmarilimab | 27-Aug-24 07:01 |